Voya Investment Management LLC Rocket Pharmaceuticals, Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 21,468 shares of RCKT stock, worth $279,942. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,468

Previous 21,847 1.73%

Holding current value

$279,942

Previous $470,000 15.74%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$17.6 - $25.88 $6,670 - $9,808	-379 Reduced 1.73%	21,468 $396,000
Q2 2024 Aug 14, 2024	BUY	$20.66 - $26.72 $24,606 - $31,823	1,191 Added 5.77%	21,847 $470,000
Q1 2024 May 15, 2024	SELL	$26.16 - $30.74 $100,140 - $117,672	-3,828 Reduced 15.63%	20,656 $556,000
Q4 2023 Feb 14, 2024	BUY	$16.78 - $31.94 $34,180 - $65,061	2,037 Added 9.07%	24,484 $733,000
Q3 2023 Nov 14, 2023	BUY	$15.07 - $24.05 $3,451 - $5,507	229 Added 1.03%	22,447 $459,000
Q2 2023 Aug 14, 2023	BUY	$16.59 - $23.6 $27,771 - $39,506	1,674 Added 8.15%	22,218 $441,000
Q1 2023 May 15, 2023	SELL	$15.79 - $22.6 $153,526 - $219,739	-9,723 Reduced 32.12%	20,544 $351,000
Q4 2022 Feb 14, 2023	SELL	$15.5 - $22.76 $156,364 - $229,602	-10,088 Reduced 25.0%	30,267 $592,000
Q3 2022 Mar 03, 2023	BUY	$12.37 - $18.41 $124,788 - $185,720	10,088 Added 33.33%	40,355 $644,000
Q3 2022 Nov 14, 2022	BUY	$12.37 - $18.41 $249,465 - $371,274	20,167 Added 99.9%	40,355 $644,000
Q2 2022 Aug 15, 2022	BUY	$7.96 - $16.64 $34,204 - $71,502	4,297 Added 27.04%	20,188 $278,000
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $5.33 Million - $8.91 Million	-247,467 Reduced 93.97%	15,891 $347,000
Q3 2021 Nov 15, 2021	SELL	$27.42 - $48.97 $427,587 - $763,638	-15,594 Reduced 5.59%	263,358 $7.87 Million
Q2 2021 Aug 16, 2021	BUY	$39.41 - $47.25 $5.15 Million - $6.18 Million	130,707 Added 88.17%	278,952 $12.4 Million
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $879,065 - $1.34 Million	-20,283 Reduced 12.04%	148,245 $6.58 Million
Q4 2020 Feb 16, 2021	SELL	$23.3 - $59.57 $982,211 - $2.51 Million	-42,155 Reduced 20.01%	168,528 $9.24 Million
Q3 2020 Nov 16, 2020	BUY	$20.5 - $28.59 $301,596 - $420,616	14,712 Added 7.51%	210,683 $4.82 Million
Q2 2020 Aug 14, 2020	SELL	$13.32 - $22.61 $1.06 Million - $1.79 Million	-79,329 Reduced 28.82%	195,971 $4.1 Million
Q1 2020 May 15, 2020	BUY	$9.71 - $25.11 $1.41 Million - $3.65 Million	145,364 Added 111.87%	275,300 $3.84 Million
Q4 2019 Feb 14, 2020	BUY	$11.07 - $24.23 $1.32 Million - $2.89 Million	119,260 Added 1117.09%	129,936 $2.96 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.81 $160,140 - $211,491	10,676 New	10,676 $160,000

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $987M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Rocket Pharmaceuticals, Inc. Transaction History